| 000 | 01667 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513100606.0 | ||
| 264 | 0 | _c19961029 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0767-3981 | ||
| 024 | 7 |
_a10.1111/j.1472-8206.1995.tb00530.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKassel, O | |
| 245 | 0 | 0 |
_aMast cell activation involves plasma membrane potential- and thapsigargin-sensitive intracellular calcium pools. _h[electronic resource] |
| 260 |
_bFundamental & clinical pharmacology _c1995 |
||
| 300 |
_a531-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium-Transporting ATPases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aExocytosis _xdrug effects |
| 650 | 0 | 4 | _aFura-2 |
| 650 | 0 | 4 |
_aHistamine Release _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aManganese _xpharmacology |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aPentetic Acid _xpharmacology |
| 650 | 0 | 4 |
_aPotassium _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aThapsigargin _xpharmacology |
| 650 | 0 | 4 |
_ap-Methoxy-N-methylphenethylamine _xpharmacology |
| 700 | 1 | _aAmrani, Y | |
| 700 | 1 | _aLandry, Y | |
| 700 | 1 | _aBronner, C | |
| 773 | 0 |
_tFundamental & clinical pharmacology _gvol. 9 _gno. 6 _gp. 531-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1472-8206.1995.tb00530.x _zAvailable from publisher's website |
| 999 |
_c8802872 _d8802872 |
||